Literature DB >> 29234161

Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.

Connie M Rhee1, Kamyar Kalantar-Zadeh2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29234161     DOI： 10.1038/nrneph.2017.174

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  13 in total

1.  Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion.

Authors:  Kamyar Kalantar-Zadeh; Raul N Uppot; Kent B Lewandrowski
Journal:  N Engl J Med       Date:  2013-07-10       Impact factor: 91.245

2.  Metformin in chronic kidney disease: more harm than help?

Authors:  Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-17       Impact factor: 32.069

3.  Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

Authors:  Robert C Stanton
Journal:  Am J Kidney Dis       Date:  2015-05-08       Impact factor: 8.860

Review 4.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

5.  Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.

Authors:  Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephron       Date:  2016-10-20       Impact factor: 2.847

6.  Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.

Authors:  Christianne L Roumie; Adriana M Hung; Robert A Greevy; Carlos G Grijalva; Xulei Liu; Harvey J Murff; Tom A Elasy; Marie R Griffin
Journal:  Ann Intern Med       Date:  2012-11-06       Impact factor: 25.391

7.  Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?

Authors:  George L Bakris; Mark E Molitch
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112

8.  Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112

9.  Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.

Authors:  Samira Bell; Bassam Farran; Stuart McGurnaghan; Rory J McCrimmon; Graham P Leese; John R Petrie; Paul McKeigue; Naveed Sattar; Sarah Wild; John McKnight; Robert Lindsay; Helen M Colhoun; Helen Looker
Journal:  BMC Nephrol       Date:  2017-05-19       Impact factor: 2.388

10.  Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.

Authors:  Paul J Connelly; Mike Lonergan; Enrique Soto-Pedre; Louise Donnelly; Kaixin Zhou; Ewan R Pearson
Journal:  Diabetes Obes Metab       Date:  2017-07-05       Impact factor: 6.577
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.